We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,291

Medicare Claims Appeals: D.C. Circuit Reverses and Remands in Case Seeking Relief From Processing Delays
  • Foley & Lardner LLP
  • USA
  • August 16 2017

On August 11, 2017, the D.C. Circuit reversed the district court and held that the district court abused its discretion by ordering the Secretary of


Lessons Learned from 2017 OCR HIPAA Enforcement Actions
  • Foley & Lardner LLP
  • USA
  • August 14 2017

So far 2017 is proving to be an active year for Health Insurance Portability and Accountability Act (HIPAA) enforcement. This comes on the heels of


A Look At The USPTO Patent Eligible Subject Matter Report
  • Foley & Lardner LLP
  • USA
  • August 8 2017

On July 24, 2017, the USPTO issued a 48-page report on Patent Eligible Subject Matter. The report summarizes key court decisions interpreting and


New Jersey’s Telemedicine Law: What Providers Need to Know
  • Foley & Lardner LLP
  • USA
  • August 7 2017

New Jersey has a new telemedicine law, recently signed by Governor Chris Christie. The law cements the validity of telehealth services in the Garden


Federal Circuit Finds Regeneron Transgenic Mouse Patent Invalid For Inequitable Conduct With Intent Inferred From Litigation Misconduct
  • Foley & Lardner LLP
  • USA
  • August 1 2017

In a 38 page decision with a 19 page dissent by Judge Newman, the Federal Circuit determined that Regeneron’s transgenic mouse patent is


OIG to Audit Medicare Telehealth Services: What You Need to Know
  • Foley & Lardner LLP
  • USA
  • July 31 2017

For what may be the first time, the Office of Inspector General (OIG) at the Department of Health & Human Services (HHS) recently announced a new


Federal Circuit Finds Velcade Patent Not Obvious Under Lead Compound Analysis
  • Foley & Lardner LLP
  • USA
  • July 25 2017

In Millennium Pharmaceuticals, Inc. v. Sandoz, the Federal Circuit reversed the district court decision that invalidated one of the Orange


State AGs Are Flexing Their Muscles to Protect Your Technology Privacy
  • Foley & Lardner LLP
  • USA
  • July 21 2017

Headlines for state Attorneys General (AGs) have been dominated by tangles with the Trump administration from the travel ban case going to the U.S


Proposed Rule Would Slash Medicare Payment for 340B Drugs
  • Foley & Lardner LLP
  • USA
  • July 20 2017

The Centers for Medicare and Medicaid Services (CMS) has proposed reducing the Medicare payment rate to hospitals for most separately payable drugs


Vermont’s New Telemedicine Law Expands Insurance Coverage, Bans Recording
  • Foley & Lardner LLP
  • USA
  • July 19 2017

Vermont health care providers and patients can now enjoy a revamped, and significantly improved, telehealth commercial insurance coverage law